Thomas L. Patz
Geschäftsführer bei Grid Therapeutics LLC
Profil
Thomas L.
Patz is currently the Chief Operating Officer & Director at Grid Therapeutics LLC and a Member at Maryland State Bar Association.
He was previously the Secretary & General Counsel at MICROS Systems, Inc. Patz received his undergraduate degree from Brown University in 1982 and his graduate degree from the University of Virginia School of Law in 1985.
Aktive Positionen von Thomas L. Patz
| Unternehmen | Position | Beginn |
|---|---|---|
| Maryland State Bar Association | Corporate Officer/Principal | - |
Grid Therapeutics LLC
 Grid Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Grid Therapeutics LLC develops and research cancer therapeutics to develop human derived antibodies. Its pipeline drugs include GT103 recombinant complement factor H monoclonal antibody and GT-20(x) recombinant monoclonal antibody. The company was founded by Edward F. Patz, Jr., Michael John Campagna and Elizabeth B. Gottlin and is headquartered in Chapel Hill, NC. | Geschäftsführer | 01.04.2017 |
Ehemalige bekannte Positionen von Thomas L. Patz
| Unternehmen | Position | Ende |
|---|---|---|
| MICROS SYSTEMS, INC. | General Counsel | - |
Ausbildung von Thomas L. Patz
| Brown University | Undergraduate Degree |
| University of Virginia School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
MICROS Systems, Inc.
 MICROS Systems, Inc. Packaged SoftwareTechnology Services MICROS Systems, Inc. develops and provides enterprise information solutions for the global hospitality industry. The firm's applications include point of sale, property management, central systems, business intelligence, ecommerce, loyalty, CRM, loss prevention, distributed order management, labor management, inventory management, and merchandise planning solutions. The company was founded in 1977 and is headquartered in Baltimore, MD. | Technology Services |
| Maryland State Bar Association | |
Grid Therapeutics LLC
Grid Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Grid Therapeutics LLC develops and research cancer therapeutics to develop human derived antibodies. Its pipeline drugs include GT103 recombinant complement factor H monoclonal antibody and GT-20(x) recombinant monoclonal antibody. The company was founded by Edward F. Patz, Jr., Michael John Campagna and Elizabeth B. Gottlin and is headquartered in Chapel Hill, NC. | Commercial Services |
